Noticias de UTHR_US

Mercado

Noticias del mercado

Últimas noticias sobre UTHR_US — 297 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: UTHR_US ✕ 297 resultados
04/08/2026 UTHR_US — Stock Titan
United Therapeutics (NASDAQ: UTHR) CEO sells 9,500 shares after option exercise
03/08/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) insider Rothblatt files to sell 199,500 shares after option exercise
03/08/2026 UTHR_US — Stock Titan
United Therapeutics Corp (UTHR) CEO sells 9,500 shares under plan
01/08/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.9m in shares By Investing.com
31/07/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.9m in shares By Investing.com
31/07/2026 UTHR_US — Investing.com ES ← EN
Rothblatt, director ejecutivo de United Therapeutics, vende 4,9 millones de dólares en acciones Por Investing.com

United Therapeutics CEO Rothblatt sells $4.9m in shares By Investing.com

31/07/2026 UTHR_US — Investing.com ES ← EN
Rothblatt, director ejecutivo de United Therapeutics, vende 4,9 millones de dólares en acciones Por Investing.com

United Therapeutics CEO Rothblatt sells $4.9m in shares By Investing.com

31/07/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) CEO trusts exercise options, sell 9,500 shares
31/07/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.9m in shares
31/07/2026 UTHR_US — tradingkey.com ES ← EN
UTHR|United Therapeutics Corp|Precio:517,710|Variación%:-8,110

UTHR|United Therapeutics Corp|Price:517.710|Chg%:-8.110

30/07/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.96 million in stock By Investing.com
30/07/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.96 million in stock By Investing.com
30/07/2026 UTHR_US — Investing.com ES ← EN
Martine Rothblatt, directora ejecutiva de United Therapeutics, vende acciones por valor de 4,96 millones de dólares

United Therapeutics CEO Martine Rothblatt sells $4.96 million in stock

30/07/2026 UTHR_US — TradingKey ES ← EN
Valoración de United Therapeutics Corp (UTHR): PE, PB y análisis de valor razonable

United Therapeutics Corp (UTHR) Valuation: PE, PB & Fair Value Analysis

30/07/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) CEO exercises 9,500 options, sells shares under plan
30/07/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.96 million in stock
29/07/2026 UTHR_US — Stock Titan
Investigational Oral PAH Drug Cuts Clinical Worsening Risk 55%
29/07/2026 UTHR_US — TradingKey
United Therapeutics Corp (UTHR) Institutional Confidence
28/07/2026 UTHR_US — Investing.com ES ← EN
Rothblatt, director ejecutivo de United Therapeutics, vende 5 millones de dólares en acciones

United Therapeutics CEO Rothblatt sells $5 million in shares

28/07/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $5 million in shares By Investing.com

Página 14 de 15